Objective Normal pressure hydrocephalus (NPH) is a neurological condition characterized by impaired gait, cognitive decline, and urinary incontinence. Endovascular shunting using the eShunt Implant ...
Background The aim of this study was to assess the technical success and procedural safety of the new Silk Vista device (SV) by evaluating the intraprocedural and periprocedural complication rate ...
Background Performing mechanical thrombectomy (MT) in patients with basilar artery occlusion (BAO) is currently not evidence-based. Objective To compare patients’ outcome, relative merits of achieving ...
Background Intracranial hemorrhage is the major safety concern of standard-dose ticagrelor (90 mg twice daily) based dual antiplatelet therapy (DAPT). The bleeding avoidance strategy through dose ...
Correspondence to Dr. Zhiming Zhou, Department of Neurology, Yijishan Hospital of Wannan Medical College, Wuhu, 241001, Anhui, China ; neuro_depar{at}hotmail.com Background Malignant brain edema (MBE) ...
Background Emergent carotid artery stenting (eCAS) is performed during mechanical thrombectomy for acute ischemic stroke due to tandem occlusion. However, the optimal management strategy in this ...
Purpose The aim of our study was to assess the technical success and the safety of this new low-profile flow diverter Silk Vista Baby (SVB) by evaluating the intraprocedural and periprocedural ...
Original research: Correlation of computed fractional flow and in-stent restenosis in patients with intracranial atherosclerotic stenosis (1 April, 2025) ...
Correspondence to Dr Robert Kyle Townsend, Neurological Surgery, Wake Forest University, Winston-Salem, NC 27157, USA; rktownse{at}wakehealth.edu Background Venous sinus stenting (VSS) is a safe, ...
Correspondence to Dr Radoslav Raychev, UCLA Department of Neurology and Comprehensive Stroke Center, Los Angeles, CA 90095, USA; rudoray{at}gmail.com Background Temporary placement of a retrievable ...
Background Clinical trials and observational studies have demonstrated the benefit of thrombectomy up to 16 or 24 hours after the patient was last known to be well. This study aimed to evaluate the ...
1 Cerebrovascular Center, Neurological Institute, Cleveland Clinic, Cleveland, Ohio, USA Background Stable access to target lesions is foundational to endovascular therapy, be it in hemorrhagic or ...